Yanchen Xie
Overview
Explore the profile of Yanchen Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li H, Xia M, Song M, Xie Y, Wang Q, Yue Y, et al.
J Neuroimmunol
. 2023 Dec;
387:578269.
PMID: 38150890
Tumor necrosis factor-alpha (TNF-α) is a potent pro-inflammatory agent involved in various autoimmune and inflammatory diseases including myasthenia gravis (MG). In this study, we enrolled 409 adult MG patients and...
2.
Li H, Jiang P, Xie Y, Liang B, Li L, Zhao C, et al.
Front Neurol
. 2022 Jun;
13:880040.
PMID: 35720071
Background: The absolute change in the severity score between the baseline and pre-specified time frame (absolute criterion) was recommended as a criterion for myasthenia gravis (MG) treatment response. But heterogeneity...
3.
Yue Y, Gao X, Tang T, Xie Y, Gu C, Hao H, et al.
J Neuroimmunol
. 2021 Feb;
353:577487.
PMID: 33578311
Complement component 3 (C3) had been proved to be involved in the pathogenesis and exacerbation of both myasthenia gravis (MG) patients and experimental autoimmune myasthenia gravis (EAMG) models. We evaluated...
4.
Jiang P, Yue Y, Hong Y, Xie Y, Gao X, Gu C, et al.
Front Neurol
. 2018 Jul;
9:529.
PMID: 30042722
Interleukin-4 (IL-4) is a potent growth and differentiation factor for B cells which play a vital role in the pathogenesis of myasthenia gravis (MG). IL-4 exerts its function by binding...
5.
Wen Q, Cao L, Yang C, Xie Y
Front Neurol
. 2018 Jul;
9:461.
PMID: 30013503
Electrophysiological examination plays an important role in the diagnosis of X-linked Charcot-Marie-Tooth disease (CMTX1) with transient central nervous system deficits. However, the electrophysiological features are seldom reported. We reviewed and...
6.
Xie Y, Li H, Sun L, Kusner L, Wang S, Meng Y, et al.
Front Neurol
. 2017 Jun;
8:230.
PMID: 28620344
Biomarkers that assess treatment response for patients with the autoimmune disorder, myasthenia gravis (MG), have not been evaluated to a significant extent. We hypothesized the pro-inflammatory cytokine, osteopontin (OPN), may...
7.
Aguilo-Seara G, Xie Y, Sheehan J, Kusner L, Kaminski H
Cytokine
. 2017 Jun;
96:279-285.
PMID: 28599246
An array of cytokines influences the pathogenesis of early onset myasthenia gravis (MG) and its animal model, experimental autoimmune myasthenia gravis (EAMG). Patients with MG, in particular those with more...
8.
Yang H, Xie Y, Zhao Y, Sun L, Zhu X, Wang S, et al.
Medicine (Baltimore)
. 2017 May;
96(20):e6798.
PMID: 28514294
In this study, we intended to genotype 2 single nucleotide polymorphisms (SNPs) of tumor necrosis factor α-induced protein 3 (TNFAIP3) genes and explore an association of TNFAIP3 genetic polymorphism with...
9.
Zhang X, Ding X, Wang Q, Yue Y, Xie Y, Hao H, et al.
J Clin Neurosci
. 2017 Mar;
40:180-184.
PMID: 28262400
Polymorphism in autoimmune regulator (AIRE) gene is associated with various autoimmune disorders. Abnormal AIRE expression is associated with the development of myasthenia gravis (MG). We investigated the association of polymorphism...
10.